HIV Diagnostic Testing in Practice: Clinical Insights, Laboratory Challenges, and Emerging Solutions

Course overview

Despite significant strides in prevention, treatment, and PrEP accessibility, infectious diseases like HIV remain a formidable global health challenge. With an estimated 41 million people living with HIV and 1.3 million new infections recorded in 2024, the mandate for timely, accurate diagnosis and immediate linkage to care has never been more critical. Because early infection is often asymptomatic, routine HIV screening and high-quality lab diagnostics serve as the primary defense in timely diagnosis and prevention efforts. Current clinical guidance emphasizes broad screening strategies and the utilization of fourth-generation HIV Ag/Ab combo assays. These advanced immunoassay HIV solutions are essential for identifying the p24 antigen, HIV-1 antibody, and HIV-2 antibody to detect both established and acute infections at the earliest possible stage. Join this SelectScience webinar with our expert panel to explore how innovation can be translated into practice through a comprehensive HIV solution, ensuring confident implementation of an HIV Ag/Ab combo screen within healthcare systems worldwide.